Introduction: The Clinical Challenge of Chronic Ataxias

Chronic ataxias, including spinocerebellar ataxias (SCAs) and Friedreich’s ataxia, are progressive neurodegenerative disorders primarily characterized by impaired coordination and gait instability. These conditions present with considerable clinical heterogeneity—ranging from cerebellar dysfunction to extracerebellar manifestations such as parkinsonism, cognitive impairment, and oculomotor abnormalities—depending on the subtype and individual presentation.¹ The gradual onset and symptom overlap with other neurological disorders often delay accurate diagnosis and subtype differentiation, hindering early intervention and targeted care.²

Advancements in genetic testing, particularly next-generation and long-read sequencing, have significantly improved diagnostic yields. However, challenges persist due to the growing number of implicated genes and variant types. In the absence of disease-modifying therapies, early detection and precise classification are essential for optimizing supportive care, rehabilitation, and prognostic planning. These complexities underscore the urgent need for innovative diagnostic tools and precision medicine approaches in the management of chronic ataxias.^3,4

AI in Early Diagnosis: From Clinical Signs to Digital Biomarkers

Artificial intelligence (AI) is increasingly redefining the early detection landscape for chronic ataxias by transforming traditional clinical observation into quantitative, objective analysis. Motion capture systems, smartphone-based sensors, and wearable devices now generate high-resolution data on motor function, enabling deep learning models to detect subtle gait abnormalities that precede clinical diagnosis.⁵

Computer vision algorithms applied to video-based gait analysis offer a scalable and non-invasive alternative, particularly valuable in remote or resource-limited settings. These technologies support early screening in both primary care and neurology, allowing clinicians to identify motor dysfunction with greater sensitivity than conventional methods.^6,7

Notably, studies have shown that wearable sensor data, when combined with deep learning algorithms, can outperform standard clinical scales in tracking disease progression in Friedreich’s ataxia. These AI-driven systems capture nuanced motor impairments that evolve over time, offering real-time monitoring capabilities that are difficult to replicate through periodic clinical visits. As AI technologies become further integrated into clinical workflows, their role in improving diagnostic accuracy, disease monitoring, and access to specialized care is poised to expand significantly.⁸

AI and Neuroimaging: Revealing Subtle Cerebellar Changes

Machine learning (ML) techniques are advancing neuroimaging interpretation by identifying cerebellar abnormalities associated with chronic ataxias that may be undetectable through visual inspection alone. Algorithms trained on multimodal data—including MRI, diffusion tensor imaging (DTI), and functional MRI (fMRI)—have demonstrated strong performance in predicting clinical scores such as the Friedreich Ataxia Rating Scale (FARS), with some models achieving an R² of 0.79.⁹

These models integrate volumetric measures of cerebellar lobules, microstructural integrity of cerebellar peduncles, and metrics from quantitative susceptibility mapping to generate sensitive imaging biomarkers. Furthermore, ML has shown utility in distinguishing between closely related ataxia subtypes, such as SCA1 and SCA3, by recognizing patterns of regional atrophy and tissue microstructure alterations that are often missed by radiologists.¹⁰

Importantly, ML also enables longitudinal tracking of cerebellar atrophy, facilitating early detection of disease progression and monitoring of therapeutic response. These advances mark a shift toward composite neuroimaging biomarkers that improve diagnostic precision, inform prognosis, and guide personalized interventions.^11,12

Genetic and Multi-Omics Integration: AI in Precision Ataxia Diagnosis

Artificial intelligence is playing a pivotal role in the genomic interpretation and molecular stratification of chronic ataxias. By efficiently parsing large-scale next-generation sequencing (NGS) data, AI models can detect pathogenic repeat expansions and rare mutations across a wide spectrum of ataxia-associated genes—addressing limitations of conventional diagnostic pipelines.¹³

In addition to variant detection, polygenic risk scores generated through AI help quantify cumulative genetic burden, enhancing phenotype-genotype correlation, especially in sporadic or atypical cases. The integration of transcriptomic and proteomic data has further expanded AI’s utility in uncovering novel biomarkers and elucidating disease pathways, offering targets for potential therapeutic development.¹⁴

One of AI’s most impactful contributions lies in its ability to reclassify variants of uncertain significance (VUS). Using predictive modeling and functional annotation tools, AI reduces diagnostic ambiguity and improves clinical decision-making. Furthermore, the combination of long-read sequencing with AI-driven multi-omics approaches has resolved previously undiagnosable cases by identifying splicing defects, compound heterozygosity, and repeat expansions with improved accuracy.¹⁵

These innovations are accelerating diagnostic workflows and paving the way for precision medicine in ataxia care—tailoring management strategies to the molecular profiles of individual patients and enhancing the potential for targeted intervention.

References:

1. Spinocerebellar ataxia. Wikipedia. 2025 Apr 6.

2. Diagnosis and management of progressive ataxia in adults. Front Neurol. 2019 May 2;10:101.

3. An Update on the Adult-Onset Hereditary Cerebellar Ataxias. J Clin Med. 2024 May 18;13(10):3456.

4. Rehabilitation in patients with cerebellar ataxias. Front Neurol. 2022 Feb 28;13:

5. AI Effective at Predicting Disease Progression in Friedreich's Ataxia. Nature Medicine. 2025 Apr 8.

6. Artificial Intelligence‐Based Virtual Assistant for the Diagnostic of Chronic Ataxias. Mov Disord.2025 Mar 22. [PMID: 40119570]

7. Artificial Intelligence-Based Virtual Assistant for the Diagnostic of Chronic Ataxias. Mov Disord.2025 Mar 22. [PMID: 40119570]

8. AI Effective at Predicting Disease Progression in Friedreich's Ataxia. Nature Medicine. 2025 Apr 8.

9. Durrant S, et al. Predictive machine learning and multimodal data to develop highly sensitive composite biomarkers of Friedreich ataxia severity and progression. Sci Rep. 2025 May 21;15(1):8457.

10. Autosomal dominant cerebellar ataxias: new genes and progress in understanding pathogenesis. Lancet Neurol. 2023 Feb;22(2):123-136.

11. Effects of physiotherapy on degenerative cerebellar ataxia: A systematic review. Front Neurol.2025 Jan 10;15:1491142.

12. Cerebellar ataxia: Clinical features and neuroimaging. Handbook of Clinical Neurology.2023;167:217-234.

13. Bahlo M, et al. Detection and discovery of repeat expansions in ataxia enabled by long-read sequencing. Nat Commun. 2023 Sep 21.

14. Kim H, et al. The genetic landscape of sporadic adult-onset degenerative ataxia. Neurogenetics. 2025.

15. Gauthier J, et al. Integration of multi-omics technologies for molecular diagnosis in ataxia patients. Front Genet. 2024 Jan 4.